Pyruvate Kinase Function Correlates With Red Blood Cell Properties and Clinical Manifestations in Sickle Cell Disease
American Journal of Hematology · 2025
DOI: 10.1002/ajh.27644 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hematology, 2025. Verfasst von M J M Traets und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Central Diagnostic Laboratory-Research, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Pyruvate Kinase, Erythrocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Agios Pharmaceuticals, Eurostars.
Abstract (Originalsprache)
Pyruvate kinase (PK) is a key enzyme involved in the final step of glycolysis, essential to produce adenosine triphosphate (ATP). Relatively decreased red blood cell (RBC) PK activity (reflected by a lower PK/hexokinase [HK] ratio) and PK thermostability (PK activity after exposure to heat) were recently identified as pathophysiological features of sickle cell disease (SCD). In this study, we investigated whether impaired PK function is associated with sickle RBC properties and SCD‐related clinical manifestations. This study included 97 non‐transfused patients with SCD (88 HbSS, 9 HbS/β0 thalassemia). PK thermostability was correlated with RBC parameters such as reticulocyte count ( r = −0.402, p < 0.0001) and hemoglobin F ( r = 0.394, p < 0.0001), and indicators of impaired functional properties of sickle RBCs, such as the point of sickling ( r = −0.417, p < 0.0001), oxygen affinity ( r = 0.408, p < 0.001) and RBC adhesion to laminin ( r = −0.322, p = 0.024). Additionally, a low PK/HK ratio correlated with decreased PK thermostability ( r = 0.308, p = 0.002), decreased RBC deformability ( r = 0.268, p = 0.009), and elevated 2,3‐diphosphoglycerate levels ( r = −0.244, p = 0.016). Multivariate Poisson regression analysis demonstrated that reduced PK thermostability and PK/HK ratio were associated with a higher incidence of SCD‐related clinical complications. For every 10‐unit decrease in PK thermostability and 1‐unit decrease in PK/HK ratio, the incidence of SCD‐related clinical complications increased by 11% ( p = 0.012) and 10% ( p = 0.019), respectively. Altogether, these findings indicate that impaired PK function is related to compromised sickle RBC properties and SCD‐related clinical manifestations. This supports the relevance and underlines the potential of PK activation therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Central Diagnostic Laboratory-Research, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
- Center for Benign Hematology, Thrombosis and Hemostasis-Van Creveldkliniek, University Medical Center Utrecht, Utrecht, the Netherlands.
- Section Metabolic Diagnostics, Department of Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
- Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands.
- Department of Hematology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
- Department of Pediatric Hematology and Oncology, Erasmus MC Sophia Children's Hospital, University Medical Center, Rotterdam, the Netherlands.
ORCID-Profile: M J M Traets, M J van Dijk, B J Biemond, M A E Rab
Förderung
- Agios Pharmaceuticals
- Eurostars
Zitieren
APA
Traets, M. J. M., Bos, J. F., van der Veen, S., van Pelt, L., van Dijk, M. J., van Oirschot, B. A., de Wilde, J. R. A., Jans, J. J., van Solinge, W. W., Schols, S. E. M., Lauw, M. N., Cnossen, M. H., Nur, E., Biemond, B. J., Rijneveld, A. W., van Beers, E. J., van Wijk, R., & Rab, M. A. E. (2025). Pyruvate Kinase Function Correlates With Red Blood Cell Properties and Clinical Manifestations in Sickle Cell Disease. American Journal of Hematology. https://doi.org/10.1002/ajh.27644
Vancouver
Traets MJM, Bos JF, van der Veen S, van Pelt L, van Dijk MJ, van Oirschot BA, et al. Pyruvate Kinase Function Correlates With Red Blood Cell Properties and Clinical Manifestations in Sickle Cell Disease. American Journal of Hematology. 2025. doi:10.1002/ajh.27644
BibTeX
@article{Traets2025,
author = {Traets, M J M and Bos, J F and van der Veen, S and van Pelt, L and van Dijk, M J and van Oirschot, B A and de Wilde, J R A and Jans, J J and van Solinge, W W and Schols, S E M and Lauw, M N and Cnossen, M H and Nur, E and Biemond, B J and Rijneveld, A W and van Beers, E J and van Wijk, R and Rab, M A E},
title = {Pyruvate Kinase Function Correlates With Red Blood Cell Properties and Clinical Manifestations in Sickle Cell Disease},
journal = {American Journal of Hematology},
year = {2025},
doi = {10.1002/ajh.27644}
}
EUVIMED